Trump Officials Move to Lower Drug Prices by Passing On Rebates to Patients

The change would disrupt longstanding payment arrangements in the pharmaceutical industry, which could lower patients’ costs but could also have unintended consequences.

from NYT > U.S. https://nyti.ms/2GgyzP5
via IFTTT